Evaluation of 2 Synthetic Nitrile Male Condoms Compared to a Standard Latex Male Condom
NCT ID: NCT05912283
Last Updated: 2024-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
600 participants
INTERVENTIONAL
2023-06-02
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom
NCT06079060
Functional Performance and Acceptability Study of Synthetic Nitrile, and Latex Graphene, Compared to Standard Latex Male Condom
NCT04881877
Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom
NCT06595836
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
NCT06557499
Evaluation of Polyurethane Male Condoms
NCT04622306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Synthetic Nitrile Condoms (53mm)
53mm width synthetic nitrile condoms
Synthetic Nitrile Condoms (53mm)
53mm width synthetic nitrile condoms
Synthetic Nitrile Condoms (56mm)
56mm width synthetic nitrile condoms
Synthetic Nitrile Condoms (56mm)
56mm width synthetic nitrile condoms
Control Latex Condom
Commercial natural rubber latex condom
Control Latex Condom
Commercial natural rubber latex condom
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Synthetic Nitrile Condoms (53mm)
53mm width synthetic nitrile condoms
Synthetic Nitrile Condoms (56mm)
56mm width synthetic nitrile condoms
Control Latex Condom
Commercial natural rubber latex condom
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be literate (able to read a newspaper or letter easily);
3. Have been in an exclusive (monogamous) sexual relationship with partner for at least 3 months; and intend to continue to be an exclusive (monogamous) sexual relationship with their spouse or partner while participating in this research study;
4. Be sexually active (defined as having at least one vaginal coital act per week);
5. Willing to give informed consent;
6. Willing to complete the male condom coital use reports;
7. Willing to use the study condoms as directed;
8. Agree to use only the study lubricant provided;
9. Agree to only use the study condoms sequentially during time of participation
10. Willing to adhere to the follow-up schedule and all study procedures;
11. Willing to provide research study staff with an address, phone number or other locator information while participating in the study;
12. Willing to participate in the study for the duration of 15 condom uses (approximately 3-5 months);
13. Willing to provide photo identification and/or have fingerprint scan to exclude co-enrolment in other research projects;
14. Female partner using hormonal or other non-barrier contraception (e.g. OCs, injectable, implant, IUD, or have had a tubal sterilization) or male partner vasectomised;
15. Agree to return any unopened condoms;
16. Male partner willing to ejaculate during vaginal intercourse;
17. Male partner willing to hold on to the condom ring when withdrawing the erect penis after sexual intercourse;
18. Agree to not bring study condoms in contact with genital or oral piercing jewelry
19. EAH: Both partners have valid personal email and operable mobile phones;
Exclusion Criteria
2. Either partner is known to be HIV positive (based on self report \[EAH\] or documented HIV-negative test result within past two months \[MRU\]);
3. Self-reported history of recurrent sexually transmitted infection (e.g. gonorrhea, syphilis, Chlamydia);
4. Male partner has known erectile or ejaculatory dysfunction;
5. Either partner has genital piercing jewelry, uses genital beading or uses sex toys, drugs, medications or non-study devices that can affect sexual performance;
6. Either partner has known sensitivities or allergies to latex, synthetic nitrile, vaginal/sexual lubricants or lubricants used on condoms;
7. Either partner reports symptoms of STI (EAH) or has observable evidence of STI as determined through syndromic diagnosis and vaginal/penile examination (MRU);
8. Either partner is currently participating in another condom study;
9. Either partner is a past or current employee of Essential Access Health, University of the Witwatersrand, or Karex;
10. Either partner is a sex worker.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Witwatersrand, South Africa
OTHER
Essential Access Health
OTHER
Sigma3 Services SARL
UNKNOWN
Karex Industries Sdn. Bhd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mags Beksinska, PhD
Role: PRINCIPAL_INVESTIGATOR
MatCH Research Unit (MRU)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Essential Access Health
Berkeley, California, United States
Essential Access Health
Los Angeles, California, United States
MRU (MatCH Research Unit)
Durban, KwaZulu-Natal, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Karex02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.